Autism spectrum disorder Mental and Behavioural Disorders Childhood autism
Conditions
Interventions
Sixty parents of children with ASD and anxiety are recruited from NHS services. Randomisation will occur through the online service ‘Sealed Envelope’ (https://www.sealedenvelope.com/). Families will b
Sponsors
Northumberland, Tyne and Wear NHS Foundation Trust
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Parents of autistic children who: 1.1. Are aged 6-16 years 1.2. Experience some anxiety 1.3. Do not have intellectual disability OR have mild to moderate intellectual disability 1.4. Have sufficient language ability to complete appropriate outcome measures (with assistance if required) 2. Parents/carers have sufficient spoken and written English to provide written informed consent, complete assessments and participate in the intervention
Exclusion criteria
Exclusion criteria: 1. Children who experience severe and complex anxiety disorder 2. Children with severe intellectual disability 3. Children with complex health conditions 4. Parents with significant mental health difficulties
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Intolerance of uncertainty is measured using target behaviour rating of target situations at baseline, immediately post treatment (or equivalent for Understanding Autism), 12 weeks and 26 weeks post treatment | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Children’s intolerance of uncertainty (parent and child reported) is measured using the Intolerance of Uncertainty Scale (IUS – P &C, Walker, 2009) at baseline, immediately post treatment (or equivalent for Understanding Autism), 12 weeks and 26 weeks post treatment 2. Children’s anxiety is measured using the Screen for Child Anxiety Related Emotional Disorders (SCARED; Birmaher et al., 1997) at baseline, immediately post treatment (or equivalent for Understanding Autism), 12 weeks and 26 weeks post treatment 3. Children’s anxiety (parent and child reported) is measured using the Anxiety Scale for Children - ASD (ASC-ASD, Rodgers et al., 2016) at baseline, immediately post treatment (or equivalent for Understanding Autism), 12 weeks and 26 weeks post treatment 4. Children’s activities and participation are measured using the Children’s Assessment of Participation and Enjoyment (CAPE, King et al., 2004) at baseline, immediately post treatment (or equivalent for Understanding Autism), 12 weeks and 26 weeks post treatment 5. Parents’ self-efficacy is measured using the Parent Self-efficacy scale (Sofronoff & Farbotko, 2002) at baseline, immediately post treatment (or equivalent for Understanding Autism), 12 weeks and 26 weeks post treatment 6. Parents’ own intolerance of uncertainty is measured using the Intolerance of Uncertainty Scale (IUS-12; Carleton, 2012) at baseline, immediately post treatment (or equivalent for Understanding Autism), 12 weeks and 26 weeks post treatment 7. Parents’ mental wellbeing is measured using the Depression, Anxiety and Stress Scale (DASS, Lovibond & Lovibond, 1995) at baseline, immediately post treatment (or equivalent for Understanding Autism), 12 weeks and 26 weeks post treatment 8. Treatment expectancy is measured using the Credibility/Expectancy Questionnaire (Devilly & Borkovec, 2000) at baseline, immediately post treatment (or equivalent for Understanding Autism), 12 weeks and 26 weeks post treatment | — |
Countries
England, United Kingdom
Outcome results
None listed